Here are five things to know:
1. The Contemporary Thoracic SCI Registry Study is a complement to InVivo’s INSPIRE study.
2. The CONTEMPO Registry Study is designed to offer natural history benchmarks for INSPIRE study results, including spinal cord injury patients with similar baseline characteristics treated since 2006.
3. The NACTN registry encompasses data from academic hospital neurosurgical departments, inclusive of acute patient data, post-injury complications and treatments, MRI data and follow-up neurological exams.
4. InVivo submitted a protocol for the CONTEMPO Registry Study to the FDA.
5. The company hopes the INSPIRE study combined with the CONTEMPO Registry Study will offer evidence for the Humanitarian Device Exemption approval process.
More articles on devices:
6 trends in the global joint reconstruction device market
SANUWAVE picks LITHOMED as orthopedic products distributor in Taiwan: 5 things to know
Zimmer Biomet, Medtronic, K2M & more: 7 device company key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
